3 Cheap Stocks to Buy for Growth & Value

05:18pm, Thursday, 04'th Jan 2024
From their current levels, it would be no surprise if Direct Digital (DRCT), Vaalco Energy (EGY), and Grifols' (GRFS) stock moved much higher in 2024.
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two companies is the best option for those looking for under
Does Grifols (GRFS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Grifols (GRFS), Denison Mine Corp (DNN), NGL Energy Partners (NGL), Macatawa Bank (MCBC) and Navient (NAVI) have been selected as the breakout stocks for today.

Grifols Is Building Momentum

05:34pm, Friday, 08'th Dec 2023
Argenx's failure removes competitive pressure on Grifols' immunoglobulin franchise. Grifols is in advanced negotiations to sell Shanghai RAAS, which would eliminate short-term debt concerns. Grifols'
Grifols, S.A. (NASDAQ:GRFS ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Nuria Pascual - IR and Sustainability Officer Thomas Glanzmann - Executive Chairman and C
Grifols shares soared in early trading on Thursday after the Spanish drugmaker upgraded its annual profit outlook following a strong quarter.
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two companies is the best option for those looking
Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

New Strong Buy Stocks for September 12th

09:05am, Tuesday, 12'th Sep 2023
TAC, GRFS, KB, BRO and GRNT have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2023.

Grifols: A Promising Buy Opportunity

10:56am, Wednesday, 05'th Jul 2023
Grifols is a promising buy opportunity thanks to its potential to reduce its net debt/EBITDA ratio. The company's focus on deleveraging is showing results and is supported by higher savings and better
I've reviewed Grifols once before and gave you my overall thesis on what I believe to be a solid pharma/biotech company. Investing in Spanish stocks without a dividend and worrying fundamentals is alw
Grifols, S.A. (NASDAQ:GRFS ) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET Company Participants Nuria Pascual - IR Thomas Glanzmann - Executive Chairman Victor Grifols Deu - Co-CEO Alfredo A

Why Shares of Grifols Were Up Tuesday

03:39pm, Tuesday, 09'th May 2023
Grifols' first-quarter report came a day after it announced a new leadership team. The company upgraded half-year and full-year guidance.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE